Endovascular Treatment of Aortobronchial Fistula Secondary to Coronary Artery Bypass Graft (CABG)
Aortobronchial fistula (ABF) is a rare and late complication of cardiac surgery. If untreated, mortality rate is approximately 100% secondary to exsanguinations haemoptysis. Early diagnosis and treatment are essential for successful management. Open surgical repair is associated with high morbidity and mortality rate, ranging from 25% to 41%. Endovascular treatments of ABF is a less invasive treatment modality and have become an important alternative to open surgical intervention in aortic pathologies. We present a case of ABF that successfully is managed by endovascular approach.
Girardet A. Doppelte perforation eines tuberkelknotens in die aorta undo die bifurcation der trachea. Dtsch Med Wochenschr 1914;40:1425-28. [in Dutchland]
Chuter TA, Ivancev K, Lindblad B, Brunkwall J, Arén C, Risberg B. Endovascular stent-graft exclusion of an aortobronchial fistula. J Vasc Interv Radiol 1996;7(3):357-9.
Picichè M, De Paulis R, Fabbri A, Chiariello L. Postoperative aortic fistulas into the airways: etiology, pathogenesis, presentation, diagnosis, and management. Ann Thorac Surg 2003;75(6):1998-2006.
Numan F, Arbatli H, Yağan N, Demirsoy E, Sönmez B. Endovascular treatment of an aortobronchial fistula. Cardiovasc Intervent Radiol 2004;27(1):71-3.
MacIntosh EL, Parrott JC, Unruh HW. Fistulas between the aorta and tracheobronchial tree. Ann Thorac Surg 1991;51(3):515-9.
Pirrelli S, Bozzani A, Arici V, Odero A. Endovascular treatment of acute haemoptysis secondary to aortobronchial fistula. Eur J Vasc Endovasc Surg 2006;32(4):366-8.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.